Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Physician Responses to Apple Watch-Detected Irregular Rhythm Alerts: A Case-Based Survey

View ORCID ProfilePatrick C. Demkowicz, View ORCID ProfileSanket S. Dhruva, Erica S. Spatz, Alexis L. Beatty, View ORCID ProfileJoseph S. Ross, View ORCID ProfileRohan Khera
doi: https://doi.org/10.1101/2022.08.02.22278237
Patrick C. Demkowicz
1Section of General Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
2Section of Cardiology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
3Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick C. Demkowicz
Sanket S. Dhruva
4Division of Cardiology, Department of Medicine, University of California San Francisco (UCSF), San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sanket S. Dhruva
Erica S. Spatz
2Section of Cardiology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
3Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexis L. Beatty
4Division of Cardiology, Department of Medicine, University of California San Francisco (UCSF), San Francisco, CA
5Department of Epidemiology and Biostatistics, UCSF, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph S. Ross
1Section of General Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
3Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT
6Department of Health Policy and Management, Yale School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joseph S. Ross
Rohan Khera
2Section of Cardiology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
3Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT
7Section of Health Informatics, Department of Biostatistics, Yale School of Public Health, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rohan Khera
  • For correspondence: rohan.khera{at}yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background While the US Food and Drug Administration (FDA) has cleared smart watch software for detecting atrial fibrillation (AF), there is lack of guidance on management by physicians.

Methods We conducted a case-based survey of physicians in primary care, emergency medicine, and cardiology at Yale and University of California San Francisco from September to December 2021. Cases described asymptomatic patients receiving Apple Watch AF alerts; cases varied in sex, race, medical (diabetes and hypertension) history, and notification frequency. Physicians were asked to select from among prespecified diagnostic testing, referral, and treatment options.

Results We emailed 636 physicians, of whom 95 (14.9%) filled out the survey, including 39 primary care, 25 emergency medicine, and 31 cardiology physicians. Among a total of 192 cases (16 unique scenarios), physicians selected at least one diagnostic test in 191 (99.5%) cases and medications in 48 (25.0%). Rates of patient referral (14%, 30%, and 16%, respectively; P=.048), rhythm monitoring (84%, 46%, and 94%, respectively; P<.001), measurement of BNP (8%, 20%, and 2%; P=.003), and use of antiarrhythmics (16%, 4%, and 23%; P=.023) varied among primary care, emergency medicine, and cardiology, respectively. Management was largely consistent across case characteristics (race, sex, medical history, and alert frequency).

Conclusion In hypothetical cases of patients presenting without clinical symptoms, physicians opted for further diagnostic testing and often to medical intervention based on Apple Watch irregular rhythm notifications. There was also considerable variation across physician specialties, suggesting a need for uniform clinical practice guidelines.

Competing Interest Statement

PD reports Roivant Sciences stock options. SD reports research funding from the Department of Veterans Affairs, from the Medical Device Innovation Consortium (MDIC) as part of the National Evaluation System for health Technology Coordinating Center (NESTcc), Greenwall Foundation, Arnold Ventures, and National Institute for Health Care Management. ES receives grant funding from the Centers for Disease Control and Prevention (20042801-Sub01), National Institute on Minority Health and Health Disparities (U54MD010711-01), the U.S. Food and Drug Administration to support projects within the Yale-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI, U01FD005938), the National Institute of Biomedical Imaging and Bioengineering (R01 EB028106-01), and from the National Heart, Lung, and Blood Institute (R01HL151240). AB was employed by Apple Inc. 2018-2019 and held stock in Apple Inc. 2019-2021. JR currently receives research support through Yale University from Johnson and Johnson to develop methods of clinical trial data sharing, from the Medical Device Innovation Consortium as part of the National Evaluation System for Health Technology (NEST), from the Food and Drug Administration for the Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938), from the Agency for Healthcare Research and Quality (R01HS022882), from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R01HS025164, R01HL144644), and from Arnold Ventures; in addition, JR is an expert witness at the request of Relator's attorneys, the Greene Law Firm, in a qui tam suit alleging violations of the False Claims Act and Anti-Kickback Statute against Biogen Inc. In addition to funding listed above, RK also receives research support, through Yale, from Bristol-Myers Squibb. He is a coinventor of U.S. Pending Patent Application No. 63/177,117, "Methods for neighborhood phenomapping for clinical trials", and U.S. Provisional Patent Application No. 63/346,610, "Articles and methods for format independent detection of hidden cardiovascular disease from printed electrocardiographic images using deep learning.” He is also a founder of Evidence2Health, a precision health platform to improve evidence-based cardiovascular care.

Funding Statement

The study was funded by the National Heart, Lung and Blood Institute (under award K23HL153775 to RK and T35HL007649 to PD), and the Doris Duke Charitable Foundation (under award, 2022060 to RK).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRBs of Yale and UCSF waived ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Presentations: Poster at the 2022 American Heart Association Quality of Care and Outcomes Research (AHA QCOR) Scientific Session (Abstract 43).

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 03, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Physician Responses to Apple Watch-Detected Irregular Rhythm Alerts: A Case-Based Survey
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Physician Responses to Apple Watch-Detected Irregular Rhythm Alerts: A Case-Based Survey
Patrick C. Demkowicz, Sanket S. Dhruva, Erica S. Spatz, Alexis L. Beatty, Joseph S. Ross, Rohan Khera
medRxiv 2022.08.02.22278237; doi: https://doi.org/10.1101/2022.08.02.22278237
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Physician Responses to Apple Watch-Detected Irregular Rhythm Alerts: A Case-Based Survey
Patrick C. Demkowicz, Sanket S. Dhruva, Erica S. Spatz, Alexis L. Beatty, Joseph S. Ross, Rohan Khera
medRxiv 2022.08.02.22278237; doi: https://doi.org/10.1101/2022.08.02.22278237

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cardiovascular Medicine
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13403)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5182)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4225)
  • Public and Global Health (7526)
  • Radiology and Imaging (1717)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (73)
  • Transplantation (237)
  • Urology (206)